Putnam Investments LLC Grifols Sa Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$18.01 - $20.11 $9.6 Million - $10.7 Million	-532,900 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $186,608 - $230,371	-10,700 Reduced 1.97%	532,900 $9.78 Million
Q4 2017 Feb 14, 2018	SELL	$20.99 - $23.89 $17.1 Million - $19.4 Million	-812,583 Reduced 59.92%	543,600 $12.5 Million
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $27.2 Million - $29.7 Million	1,356,183	1,356,183 $29.7 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.